Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

yuiyoshida

(42,722 posts)
Sun Apr 16, 2017, 09:24 PM Apr 2017

The DEA just gave a big boost to a cannabis-based seizure drug



We are often judged by the company we keep, even unfairly. For decades, that has been the fate of cannabidiol, a chemical compound that has the bad luck to occur naturally in marijuana, the world’s most controversial plant. Because cannabidiol is subject to the same tight legal restrictions on personal and scientific use as is marijuana, its potential medical benefits have been underappreciated — at least up until now.

A growing body of research suggests that cannabidiol (CBD) can reduce seizures in individuals with epileptic disorders, reducing the damage caused by these diseases as well as improving quality of life. Importantly, the drug company GW Pharmaceuticals has developed a process to extract CBD in pure form, thereby removing the psychoactive and potentially addictive effect of consuming marijuana. This CBD extract-based medication has yielded positive results in clinical trials with children suffering from forms of epilepsy such as Dravet Syndrome and Lennox-Gastaut Syndrome.

Now, the CBD extract is currently being considered for approval as a medication by the Food and Drug Administration, which would pave the path for doctors to prescribe it.

To legally approve a medicine, the FDA must have specific information on what it contains and in what specific doses. The FDA could thus never approve the whole marijuana plant as a medicine because there are many different combinations of chemicals in different concentrations from strain to strain, plant to plant, and even from one part of the same plant to another. However, a pure CBD extract that could be dosed in a standardized manner would be a different matter, and there is no barrier to the FDA going forward.

Assuming the FDA approves CBD extract as a medicine, the Drug Enforcement Administration would then have to agree to remove CBD from Schedule I of the Controlled Substances Act, which is where it now sits by virtue of being part of an illegal drug with no officially recognized medical use (marijuana). Would the DEA really consent to scheduling as a legitimate medicine an extract of a plant they have spent decades battling?

more...
https://www.washingtonpost.com/news/wonk/wp/2017/04/04/a-promising-childhood-epilepsy-treatments-biggest-hurdle-marijuana-laws/?utm_term=.400441ec382e
4 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
The DEA just gave a big boost to a cannabis-based seizure drug (Original Post) yuiyoshida Apr 2017 OP
Doesn't the DEA fall under the control of that KKK Trumphumpin Sessions Guy? GReedDiamond Apr 2017 #1
God I hope Trump doesn't fuck this up too. progressoid Apr 2017 #2
HE WILL JuJuYoshida Apr 2017 #3
How much variance is there from one batch or source to the next? JudyM Apr 2017 #4

GReedDiamond

(5,371 posts)
1. Doesn't the DEA fall under the control of that KKK Trumphumpin Sessions Guy?
Sun Apr 16, 2017, 10:30 PM
Apr 2017

...cuz, if so, don't count on anything good to happen.

Latest Discussions»Issue Forums»Cannabis»The DEA just gave a big b...